Trial Profile
Propensity score matched analysis of sitagliptin in diabetic patients with high cardiovascular risk
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2015
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions
- 21 Sep 2015 New trial record